Konstan MW - Search Results

1

Efficacy of the Flutter device for airway mucus clearance in patients with cystic fibrosis.

Konstan MW, Stern RC, Doershuk CF. Konstan MW, et al. J Pediatr. 1994 May;124(5 Pt 1):689-93. doi: 10.1016/s0022-3476(05)81356-3. J Pediatr. 1994. PMID: 8176554 Clinical Trial.

2

Ibuprofen in children with cystic fibrosis: pharmacokinetics and adverse effects.

Konstan MW, Hoppel CL, Chai BL, Davis PB. Konstan MW, et al. J Pediatr. 1991 Jun;118(6):956-64. doi: 10.1016/s0022-3476(05)82218-8. J Pediatr. 1991. PMID: 2040934 Clinical Trial.

3

Pseudomonas cepacia-associated pneumonia in cystic fibrosis. Relation of clinical features to histopathologic patterns of pneumonia.

Tomashefski JF, Thomassen MJ, Bruce MC, Goldberg HI, Konstan MW, Stern RC. Tomashefski JF, et al. Among authors: konstan mw. Arch Pathol Lab Med. 1988 Feb;112(2):166-72. Arch Pathol Lab Med. 1988. PMID: 3337628

4

Effect of high-dose ibuprofen in patients with cystic fibrosis.

Konstan MW, Byard PJ, Hoppel CL, Davis PB. Konstan MW, et al. N Engl J Med. 1995 Mar 30;332(13):848-54. doi: 10.1056/NEJM199503303321303. N Engl J Med. 1995. PMID: 7503838 Free article. Clinical Trial.

5

Cross-sectional and longitudinal studies of naturally occurring antibodies to Pseudomonas aeruginosa in cystic fibrosis indicate absence of antibody-mediated protection and decline in opsonic quality after infection.

Tosi MF, Zakem-Cloud H, Demko CA, Schreiber JR, Stern RC, Konstan MW, Berger M. Tosi MF, et al. Among authors: konstan mw. J Infect Dis. 1995 Aug;172(2):453-61. doi: 10.1093/infdis/172.2.453. J Infect Dis. 1995. PMID: 7622889

6

Identifying treatments that halt progression of pulmonary disease in cystic fibrosis.

Davis PB, Byard PJ, Konstan MW. Davis PB, et al. Among authors: konstan mw. Pediatr Res. 1997 Feb;41(2):161-5. doi: 10.1203/00006450-199702000-00001. Pediatr Res. 1997. PMID: 9029632 Clinical Trial.

7

Current understanding of the inflammatory process in cystic fibrosis: onset and etiology.

Konstan MW, Berger M. Konstan MW, et al. Pediatr Pulmonol. 1997 Aug;24(2):137-42; discussion 159-61. doi: 10.1002/(sici)1099-0496(199708)24:2<137::aid-ppul13>3.0.co;2-3. Pediatr Pulmonol. 1997. PMID: 9292910

8

Treatment of airway inflammation in cystic fibrosis.

Konstan MW. Konstan MW. Curr Opin Pulm Med. 1996 Nov;2(6):452-6. Curr Opin Pulm Med. 1996. PMID: 9363184 Review.

9

Pitfall in the use of genotype analysis as the sole diagnostic criterion for cystic fibrosis.

Chmiel JF, Drumm ML, Konstan MW, Ferkol TW, Kercsmar CM. Chmiel JF, et al. Among authors: konstan mw. Pediatrics. 1999 Apr;103(4 Pt 1):823-6. doi: 10.1542/peds.103.4.823. Pediatrics. 1999. PMID: 10103316

10

Estimating effectiveness in an observational study: a case study of dornase alfa in cystic fibrosis. The Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.

Johnson CA, Butler SM, Konstan MW, Breen TJ, Morgan WJ. Johnson CA, et al. Among authors: konstan mw. J Pediatr. 1999 Jun;134(6):734-9. doi: 10.1016/s0022-3476(99)70290-8. J Pediatr. 1999. PMID: 10356143 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters